MAPT and early-onset autosomal dominant Alzheimer disease: microRNA-137 inhibits Tau hyperphosphorylation in Alzheimer’s disease and targets the CACNA1C gene in transgenic mice and human neuroblastoma SH-SY5Y cells [26].